Blood tests can’t replace lifestyle changes for lowering dementia risk
Doctors say current Alzheimer’s blood tests are not ready for asymptomatic screening and stress that managing blood pressure, diabetes and smoking remains the most effective way to delay dementia.
Four blood assays have received FDA clearance to help clinicians confirm Alzheimer’s disease in people showing memory problems, yet they are not validated for routine screening of symptom-free adults. Specialists such as Nicholas Ashton caution that a “positive” result merely signals elevated risk and may be misleading, while negative results are more reliable. Studies show that individuals who reach midlife without hypertension, diabetes and smoking enjoy roughly 13 additional dementia-free years compared with those who have all three conditions.
Dr. Josef Coresh recommends aggressive management of these risk factors, noting benefits even for carriers of the APOE4 gene. Lifestyle interventions—including regular moderate exercise, resistance training, the MIND diet, adequate sleep, social engagement and hearing care—are presented as the proven path to protect brain health. Ongoing trials will assess whether Alzheimer’s drugs can be used preventively in people identified by blood markers.
Why it matters
Understanding the limits of blood tests and focusing on proven lifestyle changes can better protect millions from future dementia.
In this story
